PPARA and metabolic dysfunction-associated steatotic liver disease: In non-alcoholic fatty liver disease (NAFLD), lncRNA-MALAT1 regulates hepatic lipid accumulation mediated by PPARα/CD36 through the miR-206/ARNT axis, positively correlating with the severity of NAFLD [34].